Capricor Therapeutics
CAPR
#5616
Rank
NZ$2.45 B
Marketcap
NZ$42.44
Share price
1.18%
Change (1 day)
160.75%
Change (1 year)

Capricor Therapeutics (CAPR) - Total debt

Total debt on the balance sheet as of March 2026 : NZ$26.05 Million

According to Capricor Therapeutics 's latest financial reports the company's total debt is NZ$26.05 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Capricor Therapeutics - Total debt on balance sheet (from 2002 to 2026)

Total debt by year

Year Total debt Change
2024-12-31NZ$2.57 M-27.22%
2023-12-31NZ$3.53 M-12.32%
2022-12-31NZ$4.03 M-4.05%
2021-12-31NZ$4.2 M853.02%
2020-12-31NZ$0.44 M
2017-12-31N/A-100%
2016-12-31NZ$20.07 M50.07%
2015-12-31NZ$13.37 M14.48%
2014-12-31NZ$11.68 M142.39%
2013-12-31NZ$4.82 M
2006-12-31NZ$0.17 M74.31%
2005-12-31NZ$0.1 M39.4%
2004-12-31NZ$0.07 M28.16%
2003-12-31NZ$0.05 M288.54%
2002-12-31NZ$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
NZ$96.91 B 371,818.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
NZ$0.71 B 2,647.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
NZ$2.27 B 8,616.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$3.36 M-87.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$0.23 M-99.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
NZ$0.97 M-96.27%๐Ÿ‡บ๐Ÿ‡ธ USA